...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Enthusiasm? NOT!
Reply New Message
Prev Message Back To Forum Threaded View Next Message

well their hangin with some pretty good company IMO & lots going on. To be honest i cant believe were trading this low based on the presentation alone,with or without audio,Don or no Don were worth a heck of lot more than were being given credit for. Im going to grab a few more,our sp is just so undervalued IMO.

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply